UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-26 | Future report Set alerts | |
| Q2 2022 | 2022-08-02 | 2.24 | 2.24 |
| Q1 2022 | 2022-04-28 | 0.00 | 0.00 |
| Q4 2021 | 2022-02-03 | 1.63 | 1.63 |
| Q3 2021 | 2021-10-28 | 1.77 | 1.77 |
| Q2 2021 | 2021-07-29 | 1.85 | 1.85 |
| Q1 2021 | 2021-04-29 | 1.77 | 1.77 |
| Q4 2020 | 2021-02-04 | 1.53 | 1.53 |
| Q3 2020 | 2020-10-29 | 0.00 | 0.00 |
| Q2 2020 | 2020-07-30 | 1.42 | 1.27 |
| 2016-07-11 | Reiterated Rating | Nomura Holdings Inc. | Hold | |
| 2016-06-02 | Boost Price Target | SunTrust | Neutral | $27.00 to $30.00 |
| 2016-06-02 | Boost Price Target | SunTrust Banks Inc. | Neutral | $27.00 to $30.00 |
| 2016-05-29 | Reiterated Rating | Citigroup Inc. | Hold | |
| 2016-05-27 | Boost Price Target | Citigroup Inc. | Neutral | $26.50 to $28.50 |
| 2016-05-27 | Reiterated Rating | Nomura | Neutral | $28.00 |
| 2016-05-27 | Reiterated Rating | Nomura Holdings Inc. | Neutral | $28.00 |
| 2016-04-05 | Downgrade | Goldman Sachs | Neutral to Sell | $19.00 to $21.00 |
| 2016-04-05 | Downgrade | Goldman Sachs Group Inc. | Neutral to Sell | $19.00 to $21.00 |
| 2016-04-04 | Reiterated Rating | Nomura | Hold | |
| 2016-04-01 | Boost Price Target | Nomura | Neutral | $27.00 to $28.00 |
| 2016-03-22 | Initiated Coverage | SunTrust | Neutral | $23.00 |
| 2016-03-19 | Reiterated Rating | Credit Suisse | Buy | |
| 2016-03-19 | Reiterated Rating | Credit Suisse Group AG | Buy | |
| 2016-03-18 | Boost Price Target | Credit Suisse | Outperform | $24.00 to $28.00 |
| 2016-02-17 | Upgrade | Citigroup Inc. | Sell to Neutral | $20.00 |
| 2016-02-16 | Lower Price Target | Keefe, Bruyette & Woods | Market Perform | $43.00 to $23.00 |
| 2016-02-16 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $41.00 to $28.00 |
| 2016-02-16 | Lower Price Target | Goldman Sachs | Neutral | $40.00 to $19.00 |
| 2016-02-16 | Upgrade | Morgan Stanley | Equal Weight to Overweight | |
| 2016-02-16 | Upgrade | Credit Suisse | Neutral to Outperform | $28.00 to $16.50 |
| 2016-02-12 | Lower Price Target | Credit Suisse | Neutral | $44.00 to $28.00 |
| 2016-02-12 | Downgrade | Wells Fargo | Outperform to Market Perform | |
| 2016-02-12 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | |
| 2016-02-08 | Lower Price Target | Goldman Sachs | $46.00 to $40.00 | |
| 2016-02-05 | Upgrade | Susquehanna | Negative to Neutral | $31.00 to $27.00 |
| 2016-01-27 | Lower Price Target | JPMorgan Chase & Co. | $49.00 to $41.00 | |
| 2016-01-12 | Lower Price Target | Susquehanna | $32.00 to $31.00 | |
| 2016-01-12 | Lower Price Target | Goldman Sachs | $47.00 to $46.00 | |
| 2016-01-12 | Downgrade | Citigroup Inc. | Neutral to Sell | |
| 2016-01-11 | Boost Price Target | Nomura | Neutral | $32.00 to $33.00 |
| 2015-11-02 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $51.00 to $49.00 |
| 2015-10-30 | Boost Price Target | Nomura | $37.00 to $38.00 | |
| 2015-10-07 | Lower Price Target | Keefe, Bruyette & Woods | $45.00 to $42.00 | |
| 2015-10-02 | Lower Price Target | Susquehanna | Negative | $34.00 to $31.00 |
| 2015-08-27 | Lower Price Target | Citigroup Inc. | Neutral | $42.50 to $40.00 |
| 2015-08-14 | Lower Price Target | Citigroup Inc. | Neutral | $43.00 to $42.50 |
| 2015-08-06 | Lower Price Target | Nomura | Neutral | $42.00 to $40.00 |
| 2015-07-15 | Downgrade | Susquehanna | Positive to Neutral | $35.00 |
| 2015-07-10 | Boost Price Target | Citigroup Inc. | Neutral | $45.00 to $46.00 |
| 2015-06-05 | Initiated Coverage | Goldman Sachs | Neutral | $46.00 |
| 2015-05-01 | Lower Price Target | Keefe, Bruyette & Woods | Market Perform | $47.00 to $45.00 |
| 2015-01-09 | Reiterated Rating | Citigroup Inc. | Hold | $45.00 to $46.00 |
| 2015-01-05 | Upgrade | Wells Fargo & Co. | Market Perform to Outperform | |
| 2015-01-05 | Upgrade | Wells Fargo | Market Perform to Outperform | |
| 2014-10-31 | Reiterated Rating | Citigroup Inc. | Neutral | $47.00 to $45.00 |
| 2014-10-23 | Downgrade | Keefe, Bruyette & Woods | Outperform to Market Perform | |
| 2014-10-22 | Downgrade | William Blair | Outperform to Market Perform | |
| 2014-10-22 | Initiated Coverage | Keefe, Bruyette & Woods | Outperform to Outperform | $60.00 to $49.00 |
| 2014-10-22 | Downgrade | Nomura | Buy to Neutral | $45.00 |
| 2014-10-08 | Reiterated Rating | Citigroup Inc. | Neutral | $52.00 to $49.00 |
| 2014-07-31 | Downgrade | Citigroup Inc. | Buy to Neutral | $57.00 to $52.00 |
| 2014-07-31 | Lower Price Target | Credit Suisse | Neutral | $55.00 to $53.00 |
| 2014-04-24 | Reiterated Rating | Citigroup Inc. | Buy | $57.00 |
| 2014-04-09 | Reiterated Rating | Citigroup Inc. | Buy | $63.00 to $60.00 |
| 2014-04-08 | Lower Price Target | Morgan Stanley | $55.00 to $53.00 | |
| 2014-03-26 | Boost Price Target | Nomura | $62.00 to $63.00 | |
| 2014-02-12 | Lower Price Target | JPMorgan Chase & Co. | $60.00 to $58.50 | |
| 2014-01-15 | Initiated Coverage | Credit Suisse | Neutral | $51.00 |
| 2014-01-13 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | |
| 2014-01-09 | Initiated Coverage | Nomura | Buy | $59.00 |
| 2014-01-02 | Downgrade | S&P Equity Research | Buy to Hold | |
| 2013-12-12 | Upgrade | Keefe, Bruyette & Woods | Market Perform to Outperform | |
| 2013-11-13 | Reiterated Rating | Citigroup Inc. | Buy | $45.00 to $52.00 |
| 2013-11-11 | Upgrade | Susquehanna | Negative to Neutral | $31.00 to $36.00 |
| 2013-10-31 | Boost Price Target | Keefe, Bruyette & Woods | Hold | $41.00 to $44.00 |
| 2013-10-31 | Lower Price Target | JPMorgan Chase & Co. | Neutral | $49.00 to $47.00 |
| 2013-10-09 | Initiated Coverage | JMP Securities | Market Perform | |
| 2013-10-04 | Boost Price Target | Keefe, Bruyette & Woods | $39.00 to $41.00 | |
| 2013-10-03 | Boost Price Target | Morgan Stanley | Equal Weight | $40.00 to $41.00 |
| 2012-09-14 | Downgrade | UBS | Neutral to Sell | $28 to $25 |
| 2010-12-28 | Initiated | William Blair | Outperform |
| 2016-07-11 | Reiterated Rating | Nomura Holdings Inc. | Hold | |
| 2016-06-02 | Boost Price Target | SunTrust | Neutral | $27.00 to $30.00 |
| 2016-06-02 | Boost Price Target | SunTrust Banks Inc. | Neutral | $27.00 to $30.00 |
| 2016-05-29 | Reiterated Rating | Citigroup Inc. | Hold | |
| 2016-05-27 | Boost Price Target | Citigroup Inc. | Neutral | $26.50 to $28.50 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In LPLA 370 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| JANUS CAPITAL MANAGEMENT LLC | 9.00M |
| Vanguard Group, Inc | 7.12M |
| HENDERSON GROUP PLC | 5.78M |
| BlackRock Inc. | 4.84M |
| Capital Research Global Investors | 2.76M |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 2.71M |
| WELLINGTON MANAGEMENT CO LLP | 2.42M |
| WCM INVESTMENT MANAGEMENT/CA | 2.39M |
| FMR LLC | 2.17M |
| BlackRock Institutional Trust Company, N.A. | 2.15M |
| LONE PINE CAPITAL LLC | 1.98M |
| Clarkston Capital Partners LLC | 1.86M |
| ALLIANCEBERNSTEIN L.P. | 1.69M |
| Invesco Ltd. | 1.67M |
| STATE STREET CORP | 1.63M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| TPG Group Holdings (SBS) Advisors, Inc. | 8.76% (8794282) | AERI / ALDR / CDNA / CZR / EPRS / FSL / GPK / IMS / LPLA / MGNX / NCLH / NTI / OTIC / PKY / Q / ROKA / SABR / SCAI / SUP / TIPT / TMHC / TNDM / VCYT / ZMH / |
| Brown Stephanie L MD & General Counsel | 0.54% (545787) | LPLA / |
| Hellman Marco | 0.49% (492390) | LPLA / |
| Thorpe Allen R | 0.43% (433003) | APAM / LPLA / |
| Arnold Dan H. Chief Financial Officer | 0.23% (229760) | LPLA / |
| Casady Mark S Chairman & Chief Exec. Officer | 0.13% (130957) | CFG / LPLA / |
| Putnam James S | 0.12% (122280) | LPLA / |
| RIEPE JAMES S | 0.08% (79111) | GNW / LPLA / NDAQ / |
| BOYCE RICHARD W | 0.06% (59989) | LPLA / |
| Moore Robert J. President & COO | 0.06% (56668) | LPLA / |
| Brennan John Joseph | 0.05% (45883) | AXP / GE / LPLA / |
| Bergers David P. MD, Legal & Gov\'t Relations | 0.04% (43382) | LPLA / |
| SCHIFTER RICHARD P | 0.04% (37493) | AAL / CZR / LPLA / RJET / |
| Audette Matthew J Chief Financial Officer | 0.04% (35883) | ETFC / LPLA / |
| Calder Tracy MD, Deputy Chief Risk Officer | 0.03% (27644) | LPLA / |
| Seese Scott Managing Director | 0.03% (26301) | LPLA / |
| White George Burton MD, Chief Investment Officer | 0.02% (24801) | LPLA / |
| Kalbaugh John Andrew MD, Institution Services | 0.02% (24318) | LPLA / |
| Fetter Victor MD, Chief Information Officer | 0.02% (23279) | LPLA / |
| Gooley Thomas MD, Svc, Trading & Operations | 0.02% (22910) | LPLA / |
| MULCAHY ANNE M | 0.02% (20340) | JNJ / LPLA / TGT / |
| Oroschakoff Michelle MD, Chief Risk Officer | 0.02% (19861) | LPLA / |
| Morrissey William P. Jr. MD, Independent Advisor Svcs | 0.02% (18091) | LPLA / |
| Larsen Sallie R. MD, Chief Human Cap. Officer | 0.02% (18082) | LPLA / |
| DINH VIET D | 0.01% (13531) | FOXA / LPLA / REV / SGMS / |
| Parker Ryan MD, Invstmt & Planning Solutns | 0.01% (11864) | LPLA / |
| EBERHART PAULETT | 0.01% (11262) | AMD / APC / CAM / CBR / CDI / LPLA / VLO / |
| Thomas Lux EVP, CAO | 0.01% (10378) | LPLA / |
| Bruton Derek MD, National Sales Manager | 0.01% (9402) | LPLA / |
| STIEFLER JEFFREY E | 0.01% (7767) | LPLA / PAY / VNTV / |
| Buchheister Jeffrey R. EVP, Chief Accounting Officer | 0.01% (7341) | LPLA / |
| Helliker Mark MD, B/D Support Services | 0.01% (7001) | LPLA / |
| Khoury Joan D MD, Chief Marketing Officer | 0.01% (6817) | LPLA / |
| Handelsman Sharyn MD, Chief Compliance Officer | 0.01% (6478) | LPLA / |
| Schott Mary Frances MD, Client Expernce & Training | 0.01% (6446) | LPLA / |
| Glavin William Francis Jr | 0.01% (5240) | LPLA / MCI / |
UM